After a significant hiatus imposed by the COVID-19 pandemic, we hereby restart Xenotransplantation literature updates. With the recently performed clinical xenotransplantation cases and the much-heightened interest in the field, we have determined that this is an optimal time to reinstate this section. There has been an invigorated focus on unique challenges posed by pig-to-human xenotransplantation, and specific attention will be given to this aspect. In this issue, we aimed to cover the gap and compiled the most relevant publications from March 2021 to March 2023.
Keywords: Federal Drug Administration; clinical trials; genetic modifications; heart xenotransplantation; immunosuppression; kidney xenotransplantation; pig-to-human; public perception.
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.